Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,200 | 84,900 | 90,600 | 93,300 | 110,900 |
| Marketable Securities | 43,700 | 64,800 | 74,800 | 74,200 | 69,700 |
| Receivables | 138,600 | 147,000 | 122,500 | 123,400 | 103,300 |
| Inventories | 31,400 | 31,900 | 33,300 | 35,900 | 34,300 |
| TOTAL | $348,600 | $342,900 | $336,800 | $341,900 | $327,600 |
| Non-Current Assets | |||||
| PPE Net | 57,300 | 58,700 | 59,100 | 60,000 | 43,200 |
| Investments And Advances | 54,900 | 40,300 | 29,900 | 24,200 | 30,700 |
| Intangibles | 1,101,900 | 1,115,400 | 1,130,800 | 1,147,500 | 773,800 |
| TOTAL | $1,214,100 | $1,214,400 | $1,219,800 | $1,231,700 | $847,700 |
| Total Assets | $1,562,700 | $1,557,300 | $1,556,600 | $1,573,600 | $1,175,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 33,300 | 24,100 | 31,900 | 23,800 | 26,000 |
| Accrued Expenses | 78,900 | 78,800 | 73,700 | 76,400 | 68,300 |
| Other current liabilities | N/A | 3,700 | 5,300 | 5,300 | 5,300 |
| TOTAL | $117,800 | $108,900 | $113,300 | $108,000 | $102,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 233,500 | 263,400 | 273,300 | 258,000 | 9,300 |
| Deferred Revenues | 2,200 | 2,300 | 2,400 | 2,500 | 2,600 |
| Other Non-Current Liabilities | 39,900 | 37,500 | 41,900 | 40,600 | 40,400 |
| TOTAL | $356,000 | $366,700 | $379,200 | $363,400 | $107,000 |
| Total Liabilities | $473,800 | $475,600 | $492,500 | $471,400 | $209,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 73,373 | 73,272 | 74,762 | N/A |
| Common Shares | 700 | 700 | 700 | 700 | 700 |
| Retained earnings | 25,600 | 29,800 | 22,900 | 53,400 | 54,100 |
| Other shareholders' equity | -5,400 | -5,800 | -5,100 | -4,300 | -4,100 |
| TOTAL | $1,088,900 | $1,081,700 | $1,064,100 | $1,102,200 | $966,100 |
| Total Liabilities And Equity | $1,562,700 | $1,557,300 | $1,556,600 | $1,573,600 | $1,175,300 |